Aptose Biosciences Inc (APTO)
1.18
-0.01
(-0.84%)
USD |
NASDAQ |
May 17, 16:00
1.15
-0.03
(-2.54%)
After-Hours: 20:00
Aptose Biosciences Total Liabilities (Quarterly): 12.66M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 12.66M |
| December 31, 2023 | 15.89M |
| September 30, 2023 | 13.10M |
| June 30, 2023 | 12.79M |
| March 31, 2023 | 13.34M |
| December 31, 2022 | 13.29M |
| September 30, 2022 | 10.23M |
| June 30, 2022 | 9.315M |
| March 31, 2022 | 7.319M |
| December 31, 2021 | 8.289M |
| September 30, 2021 | 8.518M |
| June 30, 2021 | 8.026M |
| March 31, 2021 | 5.789M |
| December 31, 2020 | 7.347M |
| September 30, 2020 | 6.102M |
| June 30, 2020 | 6.099M |
| March 31, 2020 | 5.32M |
| December 31, 2019 | 6.55M |
| September 30, 2019 | 5.032M |
| June 30, 2019 | 4.434M |
| March 31, 2019 | 4.299M |
| December 31, 2018 | 2.789M |
| September 30, 2018 | 2.37M |
| June 30, 2018 | 2.401M |
| March 31, 2018 | 2.205M |
| Date | Value |
|---|---|
| December 31, 2017 | 1.765M |
| September 30, 2017 | 1.335M |
| June 30, 2017 | 1.006M |
| March 31, 2017 | 1.755M |
| December 31, 2016 | 1.318M |
| September 30, 2016 | 1.551M |
| June 30, 2016 | 1.392M |
| March 31, 2016 | 1.431M |
| December 31, 2015 | 1.702M |
| September 30, 2015 | 1.268M |
| June 30, 2015 | 1.237M |
| March 31, 2015 | 2.179M |
| September 30, 2014 | 1.656M |
| May 31, 2014 | 2.267M |
| February 28, 2014 | 3.323M |
| November 30, 2013 | 3.606M |
| August 31, 2013 | 2.561M |
| May 31, 2013 | 1.762M |
| February 28, 2013 | 1.400M |
| November 30, 2012 | 1.595M |
| August 31, 2012 | 1.508M |
| May 31, 2012 | 2.616M |
| February 29, 2012 | 1.586M |
| November 30, 2011 | 1.411M |
| August 31, 2011 | 1.234M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
4.434M
Minimum
Jun 2019
15.89M
Maximum
Dec 2023
8.972M
Average
8.158M
Median
Total Liabilities (Quarterly) Benchmarks
| Acasti Pharma Inc | 11.50M |
| Aurinia Pharmaceuticals Inc | 170.11M |
| Edesa Biotech Inc | 2.151M |
| Lexaria Bioscience Corp | 0.2042M |
| Xenon Pharmaceuticals Inc | 31.32M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 12.80M |
| Shareholders Equity (Quarterly) | 0.137M |